KWALITY PHARMACEUTICALS
|
KWALITY PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Equity - Authorised | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
| Equity - Issued | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Equity Paid Up | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | - | - | - | - | - |
| Total Reserves | ₹321 Cr | ₹254 Cr | ₹214 Cr | ₹190 Cr | ₹171 Cr |
| Securities Premium | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr | ₹8.47 Cr |
| Capital Reserves | - | - | - | - | - |
| Profit & Loss Account Balance | ₹312 Cr | ₹244 Cr | ₹205 Cr | ₹181 Cr | ₹161 Cr |
| General Reserves | - | - | - | - | - |
| Other Reserves | ₹0.77 Cr | ₹0.77 Cr | ₹0.76 Cr | ₹0.80 Cr | ₹0.80 Cr |
| Reserve excluding Revaluation Reserve | ₹320 Cr | ₹253 Cr | ₹213 Cr | ₹189 Cr | ₹170 Cr |
| Revaluation reserve | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr | ₹0.80 Cr |
| Shareholder's Funds | ₹332 Cr | ₹264 Cr | ₹224 Cr | ₹201 Cr | ₹181 Cr |
| Minority Interest | ₹-1.68 Cr | ₹-1.65 Cr | ₹-1.63 Cr | ₹-1.45 Cr | ₹-1.36 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹29 Cr | ₹15 Cr | ₹20 Cr | ₹27 Cr | ₹20 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹45 Cr | ₹29 Cr | ₹32 Cr | ₹39 Cr | ₹30 Cr |
| Term Loans - Institutions | - | - | - | - | - |
| Other Secured | ₹-16 Cr | ₹-14 Cr | ₹-13 Cr | ₹-12 Cr | ₹-11 Cr |
| Unsecured Loans | - | - | - | ₹0.12 Cr | ₹0.70 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | - | - | - | ₹0.12 Cr | ₹0.70 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹-2.50 Cr | ₹-1.62 Cr | ₹-0.03 Cr | ₹0.41 Cr | ₹0.28 Cr |
| Deferred Tax Assets | ₹2.50 Cr | ₹1.62 Cr | ₹0.44 Cr | - | ₹0.04 Cr |
| Deferred Tax Liability | - | - | ₹0.41 Cr | ₹0.41 Cr | ₹0.31 Cr |
| Other Long Term Liabilities | ₹6.19 Cr | - | - | - | - |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹1.18 Cr | ₹0.25 Cr | ₹0.22 Cr | ₹0.90 Cr | ₹0.75 Cr |
| Total Non-Current Liabilities | ₹34 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹21 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹102 Cr | ₹56 Cr | ₹44 Cr | ₹35 Cr | ₹35 Cr |
| Sundry Creditors | ₹102 Cr | ₹56 Cr | ₹44 Cr | ₹35 Cr | ₹35 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹30 Cr | ₹24 Cr | ₹35 Cr | ₹33 Cr | ₹41 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹8.79 Cr | ₹4.97 Cr | ₹18 Cr | ₹19 Cr | ₹19 Cr |
| Interest Accrued But Not Due | ₹0.33 Cr | ₹0.17 Cr | ₹0.19 Cr | ₹0.23 Cr | ₹0.14 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹21 Cr | ₹19 Cr | ₹16 Cr | ₹15 Cr | ₹22 Cr |
| Short Term Borrowings | ₹85 Cr | ₹83 Cr | ₹66 Cr | ₹51 Cr | ₹23 Cr |
| Secured ST Loans repayable on Demands | ₹85 Cr | ₹83 Cr | ₹66 Cr | ₹51 Cr | ₹23 Cr |
| Working Capital Loans- Sec | ₹85 Cr | ₹83 Cr | ₹66 Cr | ₹51 Cr | ₹23 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-85 Cr | ₹-83 Cr | ₹-66 Cr | ₹-51 Cr | ₹-23 Cr |
| Short Term Provisions | ₹8.59 Cr | ₹6.10 Cr | ₹6.61 Cr | ₹6.48 Cr | ₹41 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹8.20 Cr | ₹5.93 Cr | ₹6.52 Cr | ₹6.48 Cr | ₹41 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹0.39 Cr | ₹0.17 Cr | ₹0.08 Cr | - | - |
| Total Current Liabilities | ₹226 Cr | ₹170 Cr | ₹152 Cr | ₹126 Cr | ₹139 Cr |
| Total Liabilities | ₹590 Cr | ₹446 Cr | ₹394 Cr | ₹354 Cr | ₹341 Cr |
| ASSETS | |||||
| Gross Block | ₹261 Cr | ₹232 Cr | ₹207 Cr | ₹170 Cr | ₹128 Cr |
| Less: Accumulated Depreciation | ₹106 Cr | ₹86 Cr | ₹68 Cr | ₹50 Cr | ₹36 Cr |
| Less: Impairment of Assets | - | - | - | - | - |
| Net Block | ₹156 Cr | ₹146 Cr | ₹139 Cr | ₹120 Cr | ₹92 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹17 Cr | - | - | ₹14 Cr | ₹12 Cr |
| Non Current Investments | - | - | - | - | - |
| Long Term Investment | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Long Term Loans & Advances | ₹11 Cr | ₹16 Cr | ₹12 Cr | ₹11 Cr | ₹8.11 Cr |
| Other Non Current Assets | - | - | - | ₹0.93 Cr | ₹0.78 Cr |
| Total Non-Current Assets | ₹184 Cr | ₹162 Cr | ₹151 Cr | ₹146 Cr | ₹113 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | - | - | - | - | - |
| Quoted | - | - | - | - | - |
| Unquoted | - | - | - | - | - |
| Inventories | ₹78 Cr | ₹83 Cr | ₹78 Cr | ₹86 Cr | ₹53 Cr |
| Raw Materials | ₹48 Cr | ₹52 Cr | ₹49 Cr | ₹57 Cr | ₹31 Cr |
| Work-in Progress | ₹2.27 Cr | ₹2.18 Cr | ₹2.02 Cr | - | - |
| Finished Goods | ₹9.32 Cr | ₹9.69 Cr | ₹11 Cr | ₹12 Cr | ₹8.36 Cr |
| Packing Materials | ₹18 Cr | ₹19 Cr | ₹16 Cr | ₹25 Cr | ₹14 Cr |
| Stores  and Spare | ₹0.31 Cr | ₹0.26 Cr | ₹0.25 Cr | - | - |
| Other Inventory | - | - | - | ₹-7.05 Cr | - |
| Sundry Debtors | ₹280 Cr | ₹154 Cr | ₹114 Cr | ₹72 Cr | ₹69 Cr |
| Debtors more than Six months | ₹30 Cr | ₹29 Cr | ₹32 Cr | ₹29 Cr | ₹17 Cr |
| Debtors Others | ₹250 Cr | ₹125 Cr | ₹82 Cr | ₹43 Cr | ₹52 Cr |
| Cash and Bank | ₹3.59 Cr | ₹15 Cr | ₹5.94 Cr | ₹7.36 Cr | ₹13 Cr |
| Cash in hand | ₹0.48 Cr | ₹0.18 Cr | ₹0.16 Cr | ₹0.37 Cr | ₹0.64 Cr |
| Balances at Bank | ₹3.12 Cr | ₹4.08 Cr | ₹5.79 Cr | ₹6.99 Cr | ₹12 Cr |
| Other cash and bank balances | - | ₹11 Cr | - | - | - |
| Other Current Assets | ₹0.30 Cr | - | ₹7.03 Cr | - | - |
| Interest accrued on Investments | - | - | - | - | - |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | - | - | - | - | - |
| Other current_assets | ₹0.30 Cr | - | ₹7.03 Cr | - | - |
| Short Term Loans and Advances | ₹43 Cr | ₹31 Cr | ₹37 Cr | ₹42 Cr | ₹92 Cr |
| Advances recoverable in cash or in kind | ₹17 Cr | ₹8.50 Cr | ₹13 Cr | ₹10 Cr | ₹25 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹26 Cr | ₹23 Cr | ₹24 Cr | ₹31 Cr | ₹67 Cr |
| Total Current Assets | ₹406 Cr | ₹284 Cr | ₹243 Cr | ₹207 Cr | ₹228 Cr |
| Net Current Assets (Including Current Investments) | ₹180 Cr | ₹114 Cr | ₹91 Cr | ₹81 Cr | ₹88 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹590 Cr | ₹446 Cr | ₹394 Cr | ₹354 Cr | ₹341 Cr |
| Contingent Liabilities | ₹37 Cr | ₹37 Cr | ₹0.35 Cr | ₹0.51 Cr | ₹0.05 Cr |
| Total Debt | ₹130 Cr | ₹112 Cr | ₹98 Cr | ₹90 Cr | ₹54 Cr |
| Book Value | - | 253.70 | 215.31 | 192.48 | 173.81 |
| Adjusted Book Value | 318.80 | 253.70 | 215.31 | 192.48 | 173.81 |
Compare Balance Sheet of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹3,582.5 Cr | 10% | 22.5% | 203.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 10% |
22.5% |
203.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses